Detalhe da pesquisa
1.
Point-of-Care Tenofovir Urine Testing for the Prediction of Treatment Failure and Drug Resistance During Initial Treatment for Human Immunodeficiency Virus Type 1 (HIV-1) Infection.
Clin Infect Dis
; 76(3): e553-e560, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36136811